RxDoctor Payments Data

Mark Gold

Addiction Medicine · Gainesville, FLNPI 1578504593

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $328,966 of the $354,731 with a category attached, or 92.7%. Emergent Biosolutions Inc. accounts for 82.0% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2020 at $163,146 and has fallen 81.6% since, to $30,000 in 2023. Among addiction medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$354,731in general payments, 2019–2025

Across 181 payments — averaging $1959.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Emergent Biosolutions Inc.$291K
  • Welcony Inc.$34K
  • Axogen$30K

What the payments were for

  • Consulting fees$328,96693%
  • Speaking & faculty fees$16,0005%
  • Travel & lodging$9,5063%
  • Food & beverage$2590%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Emergent Biosolutions Inc.167$290,725
Welcony Inc.3$33,747
Axogen11$30,259

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$354,731 in reported general payments places this provider in the 95th percentile of 101 addiction medicine providers in Florida.

See all addiction medicine providers in Florida →

Other addiction medicine in Gainesville

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →